The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

SYDNEY, AU, Feb 15, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar covering the evolving landscape in vaccine development. Register here https://webinars.endpts.com/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/ Between 2017 and 2021, there were close to 1,400 industry-sponsored single country vaccine based... » read more

liliana
Novotech Acquires European CRO, Strengthens Global Operations
Novotech Acquires European CRO, Strengthens Global Operations

SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech’s global expansion program. EastHORN was established in 2004 and has over 250 employees. The acquisition... » read more

liliana
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Novotech Acquires US-based Drug Development Consulting Firm, CBR International

SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group. CBR was founded in 2002 as a consultancy company focused on assisting biotechnology and pharma companies navigate FDA requirements from... » read more

liliana
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate

HONG KONG, Jan 10, 2023 – (ACN Newswire via SEAPRWire.com) – China Biotech Services Holdings Limited (the “Group”; stock code: 8037. HK) has announced that its subsidiary, Asia Molecular Diagnostics Laboratory (AMDL), has been nominated as the Top Clinical Laboratory Services Company in APAC 2022 and has received the College of American Pathologists (CAP) Accreditation... » read more

liliana
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (ACN Newswire via SEAPRWire.com) – HighTide Therapeutics Inc. (“HighTide”), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the closing of a $107 million Series C/C+ financing led by the TCM Healthcare Fund of Guangdong, managed by China... » read more

liliana
Novotech is Gold Sponsor at Biotech Showcase 2023
Novotech is Gold Sponsor at Biotech Showcase 2023

SYDNEY, AU, Dec 20, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Showcase 2023. Novotech CEO Dr. John Moller and experts from the Novotech US and Asia Pacific teams will be attending the conference. Meetings can be scheduled via the... » read more

liliana
Data Shows 50% of New Trials Have Sites in Asia Pacific
Data Shows 50% of New Trials Have Sites in Asia Pacific

SYDNEY, AU, Dec 15, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of new trials had sites in Asia Pacific. According to the new publication titled “State of the Global Biotech Landscape: Where the Opportunities... » read more

liliana
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

SYDNEY, AU, Nov 11, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech’s Chief Commercial Officer Barry Murphy is Session Chair for the expert panel on How to Build and Finance an East-West MRCT Strategy Workshop at the Summit (14-16 November... » read more

liliana
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

HONG KONG, Nov 10, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as “PureFDA”) announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital. This round of funds... » read more

liliana
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper

SYDNEY, AU, Oct 25, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert guidance on pathways to USFDA approval for biotechs conducting research in China. Download whitepaper here https://novotech-cro.com/whitepapers/china-biotech-landscape-opportunities-china-and-path-usfda-approval The report was prepared for international biotechs considering... » read more

liliana
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval

SYDNEY, AU, Oct 17, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical research opportunities in Asia Pacific and the regulatory pathways to achieving FDA approval. Novotech has operations across Asia Pacific and the US offering a unique... » read more

liliana
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO

SYDNEY, AU, Oct 7, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CROs as a finalist in the Scrip Award for Best Full-Service CRO. This year the Award has been split into two categories to separate the full-service providers from the smaller... » read more

liliana
Avance Clinical Wins International Health Award for Biotech CRO Services
Avance Clinical Wins International Health Award for Biotech CRO Services

SYDNEY, AU, Sep 28, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier’s Export Awards – International Health category. The award recognises excellence in clinical services exports. Avance Clinical CEO Yvonne Lungershausen The Premier of South Australia Peter Malinauskas, and Minister... » read more

liliana
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs

SYDNEY, AU, Sep 6, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates, enabling biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside... » read more

liliana
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

SYDNEY, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled “Evolution of Clinical Trials in the Asia Pacific Region”. The report was prepared by GlobalData and confirms that “the Asia-Pacific (APAC) region was the largest contributor... » read more

liliana